Latest News about OPK
Recent news which mentions OPK
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
7 Insider Stocks to Buy as Execs Snap Them Up
February 18, 2022
From InvestorPlace
Executives Buying These 5 Penny Stocks
February 16, 2022
From Benzinga
How Concerning Is Pfizer and Opko's Latest FDA Rejection?
February 03, 2022
From Motley Fool
10 Best Stocks to Buy for Your Income-Generating Portfolio
January 28, 2022
From InvestorPlace
Why Opko Health Stock Is Crashing This Week
January 27, 2022
From Motley Fool
Stocks That Hit 52-Week Lows On Tuesday
January 25, 2022
From Benzinga
65 Biggest Movers From Yesterday
January 25, 2022
From Benzinga
From Benzinga
Why Opko Health Stock Is Off 23% Today
January 24, 2022
From Motley Fool
Mid-Day Market Update: Dow Dips 1000 Points; Exterran Shares Jump
January 24, 2022
From Benzinga
54 Stocks Moving In Monday's Mid-Day Session
January 24, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 24, 2022
From Benzinga
Benzinga Pro's Top 5 Stocks To Watch For Monday, Jan. 24, 2022: UL, SNAP, OPK, M, IBM
January 24, 2022
From Benzinga
28 Stocks Moving in Monday's Pre-Market Session
January 24, 2022
From Benzinga
From Benzinga
Pfizer - OPKO Health's Growth Hormone Deficiency Candidate Receives FDA Response Letter
January 24, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 18, 2022
From Benzinga
Sema4 Strengthens AI-Driven Genomic, Clinical Data Platform With $623M GeneDx Acquisition
January 18, 2022
From Benzinga
Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates
December 31, 2021
From Benzinga
63 Biggest Movers From Friday
December 20, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 17, 2021
From Benzinga
28 Stocks Moving In Friday's Mid-Day Session
December 17, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
October 28, 2021
From Benzinga
Earnings Scheduled For October 28, 2021
October 28, 2021
From Benzinga
This Growth Hormone Drug Could Be a Boost For Pfizer
October 05, 2021
From Motley Fool
Pfizer's Growth Hormone Candidate FDA Review Pushed By 3 Months
September 27, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.